Serum Institute of India starts manufacturing Codagenix's nasal COVID-19 vaccine
- The pre-clinical study of Codagenix's COVID-19 vaccine has showed promising results, the vaccine maker claimed
- Codagenix's COVID-19 vaccine is delivered intranasally rather than via an injection, Robert Coleman, Ph.D., CEO of Codagenix said